Patents
Nature Biotechnology 25, 989 - 990 (2007)
doi:10.1038/nbt0907-989
Gene patents and genetic testing in the United States
Roger D Klein1
Abstract
As genetic testing moves into mainstream medicine, its restriction by gene patent holders will have far-reaching, detrimental effects on the healthcare system.
- Roger D. Klein is at the H. Lee Moffitt Cancer Center & Research Institute and the Department of Interdisciplinary Oncology, University of South Florida Medical School, 12902 Magnolia Drive, Tampa, Florida 33612, USA. e-mail: roger.klein@moffitt.org
